Groowe Groowe / Newsroom / NVS
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

NVS News

Novartis AG

Cytotoxic Drugs Market Report Now Available — Forecasts Market Growth from $16.21B (2026) to $21.06B by 2031, Profiling Pfizer, Roche, Novartis, AstraZeneca, Sanofi, and 15 Other Key Players

globenewswire.com
PFE NVS AZN SNY LLY JNJ MRK AMGN BIIB GILD BMY ABBV XRAY VTRS TEVA SUN

Breast Cancer Continues to Impact Communities; Milwaukee Rallies Together to Take Action at Susan G. Komen® MORE THAN PINK Walk

businesswire.com
FOX PEP BAC LLY NVS NTRA

Global CD70-Targeting Therapies Market Report 2026 - Highlights Clinical Innovation, Pipeline Trends and Commercial Opportunities

globenewswire.com
ALLO CRSP JNJ PFE ADCT REGN MRNA BMY GILD AMGN BIIB AZN NVS LLY ABBV

Patients Representing the Power of Advanced Therapies to Take Center Stage at Emily Whitehead Foundation's 2026 Believe Ball

prnewswire.com
NVS

Global Cancer Peptide Drug Market Report 2026: Opportunities, Approved Drug Dosage, Price, Sales & Clinical Trials Insights to 2031

globenewswire.com
LLY NVS AVTX

Blood Cancer Therapeutics Market to Reach $125.5 Billion by 2030, Driven by Precision Medicine Advances and Expanding Immunotherapy Pipelines

globenewswire.com
ABBV AMGN AZN BMY ROG GILD GSK JNJ LLY MRK NVS SNY PFE JAZZ AMRX

Global Huntington's Disease Treatment Market 2026-2031 - Advancements in Novel Therapeutics to Drive Growth

globenewswire.com
PFE TEVA NBIX ALNY IONS NVS QURE SANG PTC WVE

Polypill Products Market (2026-2031) - Rising Cardiovascular Disease Burden and Need for Improved Medication Adherence to Drive Growth

globenewswire.com
ABT AZN CI RDY GSK JNJ LPCN MRK NVS PFE SNY SUN TEVA VTRS

State of the Life Sciences Industry to Be Reviewed in BCC Research's 2026 Second Quarter Outlook, Spotlighting AI-Driven Discovery, Precision Oncology, and Connected Health Adoption

globenewswire.com
TEVA AZN GSK NVS PFE JNJ BMY MRK LLY REGN ILMN CHTR EVO AMGN ABT GH

Dravet Syndrome Market Trends Indicate Sustained Growth During the Forecast Period (2026–2036), Driven by Novel Treatment Approaches | DelveInsight

globenewswire.com
BIIB HRMY XNCR AZN LLY PFE REGN NVS TSLA TAK GSK JNJ UCB BHF PRAX XENE AQST TNDM INCY MRK ABBV BMY AMGN GILD VRTX CRSP EDIT NTLA SRPT ALNY EXAS TEVA AXSM CYTK INSM KODK LPCN MNKD NBIX NCLH ONCY ORIC PBYI PEGA PLRX PRGS QGEN RGNX ROST RYAAY SNOW SWKS SYK TGT TRMB TXG ULTA VRSK WDC WVE XOM ZBRA ZNTL ZTS STOK IONS MOMO BBAR CTXR MBIO GNS NEON OVID BHVN